Maurits Vissers
www.linkedin.com
0000-0001-7199-7301
Centre for Human Drug Research
3 papers found
Refreshing results…
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial
Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders
The impact of the global COVID‐19 pandemic on the conduct of clinical trials. Return to normalcy by considering the practical impact of a structured ethical analysis
Missing publications? Search for publications with a matching author name.